Do you have questions about your NCI application or award for training in cancer research or education? Make the NCI Frequently Asked Questions your first stop to getting answers!
To stay up to date on Funding for Cancer Training news, subscribe to the Cancer Training Branch Newsletter!
The NCI Predoctoral to Postdoctoral Fellow Transition (F99/K00) Award supports outstanding Ph.D. and other Research Doctoral candidates complete their dissertation research training (F99 phase) and transition in a timely manner to mentored, cancer-focused postdoctoral career development research positions (K00 phase).
Note: The details on this page are for informational purposes only. Please read and follow all requirements and instructions in the notice of funding opportunity (NOFO) and the Table of IC-Specific Information linked therein before applying for an award. Application review information is described in the funding opportunity. If you have any questions before submitting your application, please contact the relevant NCI program staff listed at the end of this page.
Learn more about the F99/K00 Award by viewing this year’s NCI F99/K00 Predoc to Postdoc Award funding opportunity RFA-CA-23-042 (F99 Predoctoral to Postdoctoral Fellow Transition Award). See also the PDF versions of slides presented in webinars on August 11 and August 18, 2020 with recording under Resources.
Applicants for the F99 should be 3rd - or 4th-year graduate students nominated by their institutions.
The F99 Research Training Plan should be developed in collaboration between the sponsor and F99 candidate. The F99 project can be within the overall scope of the sponsor’s research awards. However, NCI expects the F99 candidate to make significant intellectual contributions to the project and write the Research Training Plan. There should be no text duplication or substantial duplication of the scientific aims, and the candidate ’s application should propose a scientific research question or approach that is distinct from the specific aims of the sponsor’s pending or active research grants.
NCI will not support both a fellowship award and an active or pending research grant that propose substantially the same research.
Applications are due on November 17, 2023 or November 19, 2024. Interested applicants should review the Funding Opportunity Announcement, the material under Resources, and/or contact the Program Director.
Citizens, Foreign Nationals, and U.S. Visa Holders |
|
---|---|
Degree/Academic Appointment |
|
Geographic Location |
F99/K00 recipients must reside in and work at U.S.-based institutions for the duration of the award. However, foreign components are allowed. |
Effort Level/ Commitment |
F99 phase: At least 40 hours per week, full-time effort, to the training program K00 phase: At least 9 calendar months (75%) full-time professional effort |
Duration of the Award |
|
F99 phase: Stipend, Tuition and Fees, and Institutional Allowance
K00 phase: Salary and Fringe Benefits, Tuition and Fees, Research and Career Development Support, and Indirect Costs
Stipends/Salaries |
|
---|---|
Tuition and Fees |
NCI will pay 60% of the combined cost of tuition and fees, up to $16,000 (F99 phase) or $4,500 (K00 phase) per year. |
Training-Related Expenses and Health Insurance |
F99 phase: NCI will provide $1500 in the first year to defray the travel costs to attend a mandatory NCI-sponsored conference, and an Institutional Allowance to help defray the cost of fellowship expenses such as health insurance, research supplies, equipment, books, and travel to scientific meetings. K00 phase: NCI will provide $1500 in the first year to defray the travel costs to attend a mandatory NCI-sponsored conference, and up to $3000 annually to help defray other research training expenses, such as:
|
Indirect Costs |
F99 phase: NCI does not separately reimburse indirect costs for fellowships. Costs for administering the F99 awards are part of the Institutional Allowance. K00 phase: Indirect Costs are reimbursed at 8% of modified total direct costs. |
When the Funding Opportunity Announcement instructions deviate from those in the Application Guide, follow the instructions in the Funding Opportunity Announcement.
All applicants must use these two Specific Aims:
Specific Aim 1: The Dissertation Research Project: Provide a detailed description of the research to be completed in the F99 phase.
Specific Aim 2: The Postdoctoral Research Direction: Identify the research direction to be pursued for the K00 phase.
Research Strategy: If the applicant is proposing to gain experience in a clinical trial as a part of their research training, describe the relationship of the proposed research project to the clinical trial.
Specific Aim 1: Significance
Provide an overview of the dissertation research, including the scientific question being addressed and its potential impact on the dissertation research field.
Specific Aim 1: Approach
Provide an overview of the dissertation research, including the background, goal, rationale and hypotheses of the research project(s). The Approach for this Aim should be organized into two sections:
Specific Aim 2: Significance
Explain the significance of the K00 research direction. Describe a specific scientific question or observation that will be investigated. Explain how this question or observation is related to the applicant’s research interests and how this work will help advance this research direction.
Specific Aim 2: Approach
Provide a general description of how the research will be conducted, including approaches and methodologies to be used, anticipated results, challenges that might arise and how to address them.
Applications that do not comply with these instructions may be delayed or not be accepted for review.
For assistance with application submission, please see the Frequently Asked Questions and/or contact eRA Commons Help Desk/Grant.gov Contact Center.
Applications are due on November 17, 2023 or November 19, 2024 at 5 pm local time of the submitting institution. There is only one application due date per fiscal year for this Funding Opportunity Announcement.
An appropriate Scientific Review Group (SRG), along with NCI and the National Cancer Advisory Board (NCAB), will evaluate applications for completeness and conformance with eligibility requirements and special provisions and requirements. Incomplete applications will be returned to the applicant without further consideration. An SRG convened by the Division of Extramural Activities of the NCI will determine if applications meet the broad needs of the program and priorities of NCI.
For review criteria for the F99 grant mechanism, see the Section V. Review Information section of the Funding Opportunity Announcement.
A postdoctoral position (or equivalent) must be offered and accepted. The K00 phase institution should submit an application on behalf of the candidate for the K00 Award using Career Development (K) instructions in the SF424 (R&R) Application Guide, as well as any instructions found in Section VI.2 of the Funding Opportunity Announcement. The NCI strongly encourages institutions to submit the applications at least 6 months prior to the proposed activation date of the K00 Award to allow adequate time for review of the application. This will also ensure the transition to the K00 phase takes place without interruption in funding. The K00 application must include:
For additional information regarding policies and/or guidance in preparing an application for the F99/K00 Award, contact: